Genotyping Market to Reach $46,917.6 Million in 2035, Growing at 11.3% CAGR

Genotyping market valued at $16,203.5 million in 2025 and is projected to reach $46,917.6 million by 2035, growing at a CAGR of 11.3% during the forecast period (2026-2035). The market encompasses technologies and consumables used to analyze genetic variations, supporting applications across research, diagnostics, and drug development. The market is experiencing strong global growth driven by the rising demand for precision medicine, increasing prevalence of genetic disorders, and expanding applications of genomics in healthcare and life sciences. Growth is further supported by declining sequencing costs, advancements in high-throughput genotyping technologies, and increasing adoption of genomics in clinical decision-making. Pharmaceutical and biotechnology companies are investing heavily in genotyping platforms to accelerate target identification, biomarker discovery, and patient stratification. Additionally, the integration of AI and bioinformatics tools is enhancing data interpretation, improving efficiency, and enabling large-scale genomic studies. According to global health and genomic research organizations, the rapid expansion of genomic databases and population-scale sequencing initiatives has significantly strengthened the role of genotyping in modern healthcare. Large-scale genomic data generation and analysis are supporting advancements in disease prediction, early diagnosis, and development of targeted therapies, thereby driving long-term market growth.

Browse the full report description of “Genotyping Market Size, Share & Trends Analysis Report by Products (Kits, Reagents and Instruments), by Technology (Mass Spectrometry, Microarray, Sequencing, PCR, Electrophoresis, and Others) by Application (Drug Discovery, Personalized Medicine, Pharma Genomics, and Diagnostic Research) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/genotyping-market

Key Statistics: Genotyping at a Glance

• More than 30 million genetic tests are performed annually globally, reflecting the growing demand for genotyping technologies in clinical and research settings.
• The cost of whole genome sequencing has declined by over 90% in the past decade, significantly accelerating adoption of genotyping platforms.
• Genetic disorders affect approximately 1 in 10 individuals globally, increasing the need for advanced genotyping solutions in diagnostics and personalized medicine.

Key Innovators Driving Genotyping Transformation

The key players in the genotyping market include Agilent Technologies, Inc., Danaher Corporation, Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc, among others.

• In July 2025, Thermo Fisher Scientific introduced an advanced genotyping assay platform designed to deliver faster turnaround times and improved accuracy for large-scale genetic analysis, enhancing its portfolio in clinical and research applications.
• In May 2025, Illumina, Inc. expanded its genotyping solutions portfolio with new microarray technologies aimed at supporting population genomics and precision health initiatives, enabling more comprehensive and scalable genetic studies.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Products
  • By Technology
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Agilent Technologies, Inc., Danaher Corporation, Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Genotyping Market Report Segment

By Products

• Kits
• Reagents
• Instruments

By Technology

• Mass Spectrometry
• Microarray
• Sequencing
• PCR
• Electrophoresis
• Others

By Application

• Drug Discovery
• Personalized Medicine
• Pharma Genomics
• Diagnostic Research

Global Genotyping Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/genotyping-market